Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies

QR Code

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies

Stanley Schwartz1, Benjamin A Kohl21Department of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania, Philadelphia, Pennsylvania, USA; 2Department of Anesthesiology and Critical Care, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USAAbstract: The rates...

Description complète

Enregistré dans:

Détails bibliographiques
Auteur principal:	Schwartz S
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2010
Sujets:	Type 2 Diabetes diabetes treatment incretin-based therapies glucose control GLP-1 Cardiovascular disease Specialties of internal medicine RC581-951
Accès en ligne:	https://doaj.org/article/a245e6dfd42d4d1c8328cb70f5ab4c3a
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

New treatments in the management of type 2 diabetes: a critical appraisal of saxagliptin
par: Gallwitz B
Publié: (2010)

The role of incretin-based therapies in the management of type 2 diabetes mellitus: perspectives on the past, present and future
par: Juris J. Meier
Publié: (2019)

Role of incretin based therapies in the treatment of diabetic kidney disease
par: Paola Fioretto, et autres
Publié: (2018)

Dual GIP–GLP1-Receptor Agonists In The Treatment Of Type 2 Diabetes: A Short Review On Emerging Data And Therapeutic Potential
par: Bastin M, et autres
Publié: (2019)

Incretins in the Therapy of Diabetic Kidney Disease
par: Agnieszka Przezak, et autres
Publié: (2021)

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
par: Stanley Schwartz, et autres
Publié: (2010)

Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes – a review
par: Knop FK, et autres
Publié: (2010)

Incretin-based therapy: renal effects
par: Anton Ivanovich Korbut, et autres
Publié: (2016)

New glance at pathogenesis of type 2 diabetes mellitus: incretin and antiincretin systems.
par: Ekaterina Alekseevna Shestakova
Publié: (2011)

Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus
par: Kushner P
Publié: (2010)

A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives
par: Reed J, et autres
Publié: (2021)

Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany
par: Qiao Q, et autres
Publié: (2016)

Combination of Metformin and Exercise in Management of Metabolic Abnormalities Observed in Type 2 Diabetes Mellitus
par: Jevtovic F
Publié: (2021)

Comparative Effectiveness of Long-Acting GLP-1 Receptor Agonists in Type 2 Diabetes: A Short Review on the Emerging Data
par: Chudleigh RA, et autres
Publié: (2020)

Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data
par: Kugler AJ, et autres
Publié: (2018)

The Triglyceride–Glucose Index is Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes: A Hospital-Based, Nested, Case–Control Study
par: Yao L, et autres
Publié: (2021)

Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome
par: Davies MJ, et autres
Publié: (2017)

Association of Glycated Albumin/Glycosylated Hemoglobin Ratio with Blood Glucose Fluctuation and Long-Term Blood Glucose Control in Patients with Type 2 Diabetes Mellitus
par: Wang BR, et autres
Publié: (2021)

Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes
par: Sikirica MV, et autres
Publié: (2017)

Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
par: Seewoodhary J, et autres
Publié: (2010)

Predictors of Insulin Treatment During Pregnancy and Abnormal Postpartum Glucose Metabolism in Patients with Gestational Diabetes Mellitus
par: Tang L, et autres
Publié: (2019)

The associations of incretin hormone concentration with gestational diabetes mellitus
par: Tatiana V. Saprina, et autres
Publié: (2016)

Identification of Significant Predictors for the Need of Insulin Therapy and Onset of Postpartum Impaired Glucose Tolerance in Gestational Diabetes Mellitus Patients
par: Wang T, et autres
Publié: (2021)

The Factors Influencing the Renal Glucose Threshold in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
par: Cui SS, et autres
Publié: (2021)

The Prevalence and Control of Type 2 Diabetes Mellitus in Residents of a Rural Town, Shandong Province, China
par: Wei M, et autres
Publié: (2021)

Inсretin-based therapy in patients with type 2 diabetes and chronic kidney disease
par: Minara Shamkhalovna Shamkhalova, et autres
Publié: (2012)

First GLP-1 analog liraglutide: the result of clinical trails on efficacy
par: Alexander Sergeevich Ametov, et autres
Publié: (2011)

Effects of coenzyme Q10 on cardiovascular and metabolic biomarkers in overweight and obese patients with type 2 diabetes mellitus: a pooled analysis
par: Huang H, et autres
Publié: (2018)

The role of Leu260Phe polymorphism of the receptor gene to GLP-1 incretin in the pathogenesis of diabetes type 2 diabetes with obesity
par: Daria A. Skuratovskaia, et autres
Publié: (2019)

New indications for exenatide therapy of type 2 diabetes mellitus
par: Olga Konstantinovna Vikulova, et autres
Publié: (2010)

The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect
par: Enrique Z. Fisman, et autres
Publié: (2021)

Vildagliptin and its role in the treatment of diabetes mellitus
par: Yury Shavkatovich Khalimov
Publié: (2010)

The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia
par: Alzaheb RA, et autres
Publié: (2018)

Cognitive impairment in patients with type 2 diabetes mellitus: prevalence, pathogenetic mechanisms, the effect of antidiabetic drugs
par: Olga D. Ostroumova, et autres
Publié: (2018)

Glycemic control and diabetes complications among diabetes mellitus patients attending at University of Gondar Hospital, Northwest Ethiopia
par: Fasil A, et autres
Publié: (2018)

Sitagliptin Increases Beta-Cell Function and Decreases Insulin Resistance in Newly Diagnosed Vietnamese Patients with Type 2 Diabetes Mellitus
par: Le TD, et autres
Publié: (2020)

Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia
par: Biadgo B, et autres
Publié: (2016)

Detrimental Effect of C-Reactive Protein on the Cardiometabolic Cells and Its Rectifying by Metabolic Surgery in Obese Diabetic Patients
par: Sun F, et autres
Publié: (2020)

Nomogram for the Risk of Diabetic Nephropathy or Diabetic Retinopathy Among Patients with Type 2 Diabetes Mellitus Based on Questionnaire and Biochemical Indicators: A Cross-Sectional Study
par: Shi R, et autres
Publié: (2020)

Predictors of Diabetes Self-Care Practice Among Patients with Type 2 Diabetes in Public Hospitals in Northeastern Ethiopia: A Facility-Based Cross-Sectional Study
par: Gulentie TM, et autres
Publié: (2020)